{"id":"epinephrin","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[{"effect":"Positional headaches","drugRate":"3%","severity":"common","organSystem":""},{"effect":"Hypotension","drugRate":"3%","severity":"common","organSystem":""},{"effect":"Backache","drugRate":"3%","severity":"common","organSystem":""},{"effect":"Shivering","drugRate":"2%","severity":"common","organSystem":""},{"effect":"Dizziness","drugRate":"","severity":"common","organSystem":""},{"effect":"Drowsiness","drugRate":"","severity":"common","organSystem":""},{"effect":"Lightheadedness","drugRate":"","severity":"common","organSystem":""},{"effect":"Nervousness","drugRate":"","severity":"common","organSystem":""},{"effect":"Apprehension","drugRate":"","severity":"common","organSystem":""},{"effect":"Confusion","drugRate":"","severity":"common","organSystem":""},{"effect":"Blurred or double vision","drugRate":"","severity":"common","organSystem":""},{"effect":"Vomiting","drugRate":"","severity":"common","organSystem":""},{"effect":"Tinnitus","drugRate":"","severity":"common","organSystem":""},{"effect":"Tremors","drugRate":"","severity":"common","organSystem":""},{"effect":"Twitching","drugRate":"","severity":"common","organSystem":""},{"effect":"Paresthesia of lips, tongue, and oral tissues","drugRate":"","severity":"common","organSystem":""}],"contraindications":["Acute nephropathy","Angina pectoris","Angle-closure glaucoma","Anterior uveitis","Aphakia","Atrial fibrillation","Bacterial septicemia","Benign prostatic hyperplasia","Bleeding","Bradycardia","Cardiogenic shock","Cerebral arteriosclerosis","Chronic heart failure","Chronic myocardial ischemia","Complete atrioventricular block","Conduction disorder of the heart","Decreased respiratory function","Deficiency of cholinesterase","Denuded skin","Diabetes mellitus","Disease of liver","Disorder of cardiovascular system","Disorder of coronary artery","Heart block","Hepatic failure","Hypercapnia","Hypertensive disorder","Hyperthyroidism","Hypokalemia","Hypovolemia","Hypoxia","Iritis","Keratitis","Kidney disease","Lidocaine Toxicity","Myasthenia gravis","Myocardial infarction","Occlusive Vascular Disease","Open wound","Parkinsonism","Partial atrioventricular block","Peripheral vascular disease","Primary dilated cardiomyopathy","Psychoneurotic personality disorder","Pupillary Block Glaucoma","Reduced Hepatic Blood Flow","Regional Anesthesia for Labor Pain","Retinal detachment","Seizure disorder","Sepsis syndrome","Shock","Sinus bradycardia","Sinus tachycardia","Stokes-Adams syndrome","Thrombosis","Wolff-Parkinson-White pattern"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[{"effect":"Convulsions","drugRate":"","severity":"serious"},{"effect":"Respiratory depression and arrest","drugRate":"","severity":"serious"},{"effect":"Unconsciousness","drugRate":"","severity":"serious"},{"effect":"Severe, persistent hypertension","drugRate":"","severity":"serious"},{"effect":"Cerebrovascular accidents","drugRate":"","severity":"serious"},{"effect":"Bradycardia","drugRate":"","severity":"serious"},{"effect":"Cardiac arrest","drugRate":"","severity":"serious"},{"effect":"Methemoglobinemia","drugRate":"","severity":"serious"},{"effect":"Chondrolysis with intra-articular infusion","drugRate":"","severity":"serious"},{"effect":"Persistent paresthesia lasting weeks to months or greater than one year","drugRate":"","severity":"serious"}]},"trials":[],"_chembl":null,"aliases":["Adrenalin Chloride, Epipen","Adrenaline","Adrenalin"],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":{"setId":"74bad838-2800-4d36-a3ee-cc1d739d24c2","title":"XYLOCAINE (LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [SPORTPHARM LLC]"},"ecosystem":[],"mechanism":{"target":"Alpha-1A adrenergic receptor, Alpha-1B adrenergic receptor, Alpha-1D adrenergic receptor"},"_scrapedAt":"2026-03-27T23:45:37.900Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Acute exacerbation of asthma","diseaseId":"acute-exacerbation-of-asthma","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Administration of Local Anesthetic Nerve Block","diseaseId":"administration-of-local-anesthetic-nerve-block","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Allergic Reactions","diseaseId":"allergic-reactions","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Anaphylaxis","diseaseId":"anaphylaxis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Asthma management","diseaseId":"asthma-management","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Bronchiectasis","diseaseId":"bronchiectasis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Bronchitis","diseaseId":"bronchitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Dyspnea","diseaseId":"dyspnea","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Exacerbation of asthma","diseaseId":"exacerbation-of-asthma","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Hypotension associated with septic shock","diseaseId":"hypotension-associated-with-septic-shock","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Local anesthesia, by infiltration","diseaseId":"local-anesthesia-by-infiltration","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Low blood pressure","diseaseId":"low-blood-pressure","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Open-angle glaucoma","diseaseId":"open-angle-glaucoma","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Pulmonary emphysema","diseaseId":"pulmonary-emphysema","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Wheezing","diseaseId":"wheezing","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT06925737","phase":"PHASE3","title":"A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-05-13","conditions":"Prostate Cancer, Prostatic Neoplasms","enrollment":1440},{"nctId":"NCT06317662","phase":"PHASE2","title":"Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2025-06-05","conditions":"Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia","enrollment":153},{"nctId":"NCT04439357","phase":"PHASE2","title":"Testing Trametinib as a Potential Targeted Treatment in Cancers With GNAQ or GNA11 Genetic Changes (MATCH-Subprotocol S2)","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2016-02-25","conditions":"Advanced Lymphoma, Advanced Malignant Solid Neoplasm, Hematopoietic and Lymphoid Cell Neoplasm","enrollment":4},{"nctId":"NCT07498374","phase":"NA","title":"Efficacy and Safety of Fully Resorbable Sinus Drug-eluting Stents in Patients With Eosinophilic Chronic Rhinosinusitis With Nasal Polyps After Surgery: A Prospective, Randomized Controlled Trial","status":"RECRUITING","sponsor":"Tang-Du Hospital","startDate":"2026-01-21","conditions":"Eosinophilic Chronic Rhinosinusitis With Nasal Polyps","enrollment":192},{"nctId":"NCT03374215","phase":"","title":"Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks","status":"RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2017-12-14","conditions":"Adrenal Gland Neoplasm, Hypertension, Bone Diseases, Metabolic","enrollment":1150},{"nctId":"NCT05789030","phase":"NA","title":"Treatment Strategies for IgG4-RD Patients With Superficial Organ Involvement","status":"RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2022-07-01","conditions":"Autoimmune Diseases","enrollment":60},{"nctId":"NCT07494084","phase":"PHASE4","title":"Sleep Loss and Circadian Misalignment - Mechanisms of Insulin Resistance","status":"NOT_YET_RECRUITING","sponsor":"Washington State University","startDate":"2026-05-01","conditions":"Shift Work Schedule, Circadian Rhythm, Insulin Resistance","enrollment":24},{"nctId":"NCT06900153","phase":"","title":"Parenting and CAH - 21-hydroxylase Deficiency","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-03-16","conditions":"CAH - 21-Hydroxylase Deficiency","enrollment":200},{"nctId":"NCT07066306","phase":"NA","title":"Effects of Local Ketamine in Orthognathic Procedures","status":"ACTIVE_NOT_RECRUITING","sponsor":"Bezmialem Vakif University","startDate":"2025-06-21","conditions":"Dentofacial Deformities, Analgesia, Vomiting, Postoperative","enrollment":40},{"nctId":"NCT07410000","phase":"NA","title":"Ultrasound-Guided Quadro-Iliac Plane Block for Pain Management After Total Hip Arthroplasty","status":"RECRUITING","sponsor":"Bursa City Hospital","startDate":"2026-03-16","conditions":"Pain Management, Total Hip Arthroplasty","enrollment":100},{"nctId":"NCT05754892","phase":"NA","title":"Positioning of Molecular Markers in Clinical Routine for the Management of Patients With Adrenal Cancers/Tumors (COMETE-CARE)","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-10-01","conditions":"Cancer, Adrenal","enrollment":450},{"nctId":"NCT07361874","phase":"NA","title":"IMPACT-MACS: Adrenalectomy vs Semaglutide for Metabolic Outcomes in Mild Autonomous Cortisol Secretion","status":"RECRUITING","sponsor":"University of Texas Southwestern Medical Center","startDate":"2026-03-05","conditions":"Mild Autonomous Cortisol Secretion (MACS), Autonomous Cortisol Secretion (ACS), Subclinical Cushing's","enrollment":75},{"nctId":"NCT00004847","phase":"PHASE1","title":"Diagnosis of Pheochromocytoma","status":"RECRUITING","sponsor":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","startDate":"2000-03-22","conditions":"Pheochromocytoma, Endocrine Disease, Endocrine Diseases","enrollment":3000},{"nctId":"NCT01005654","phase":"","title":"Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2009-10-07","conditions":"Endocrine Tumors, Thyroid Neoplasms, Parathyroid Neoplasms","enrollment":2415},{"nctId":"NCT02465060","phase":"PHASE2","title":"Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2015-08-17","conditions":"Advanced Lymphoma, Advanced Malignant Solid Neoplasm, Bladder Carcinoma","enrollment":6452},{"nctId":"NCT07498465","phase":"PHASE1","title":"A Study to Find the Highest Dose of SNDX-5613 (Revumenib) as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, and Mixed Phenotype Acute Leukemia","status":"NOT_YET_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2026-09-10","conditions":"Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Childhood Acute Lymphoblastic Leukemia","enrollment":29},{"nctId":"NCT06749158","phase":"NA","title":"Radiographic and Histological Assessment of GBR Using DBB Compared to Spontaneous Bone Regeneration of Maxillary Defects , Resulted From Enucleation of Intra-bony Cystic Lesions","status":"COMPLETED","sponsor":"Cairo University","startDate":"2024-12-30","conditions":"Maxillary Cyst","enrollment":44},{"nctId":"NCT07270549","phase":"PHASE1, PHASE2","title":"Gene Replacement Therapy for Treatment of Paediatric Patients With CTNNB1 Neurodevelopmental Syndrome","status":"RECRUITING","sponsor":"CTNNB1 Foundation","startDate":"2025-11-01","conditions":"CTNNB1 Neurodevelopmental Syndrome","enrollment":12},{"nctId":"NCT07094542","phase":"PHASE2","title":"Jaw Muscle Pain Post Wisdom Molar Surgery","status":"NOT_YET_RECRUITING","sponsor":"Rutgers, The State University of New Jersey","startDate":"2026-05","conditions":"Post Operative Pain, Impacted Third Molar Tooth, Muscle Pain","enrollment":80},{"nctId":"NCT06136650","phase":"PHASE3","title":"A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2023-12-18","conditions":"Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Neoplasms","enrollment":1314},{"nctId":"NCT04959123","phase":"NA","title":"Does the Common Practice of Adding Diluted Epinephrine in Tranverse Abdominal Plan Block to Ropivacaine Significantly Decrease the Peak Systemic Resorption of Ropivacaine?","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nice","startDate":"2021-12-06","conditions":"Bowel Disease","enrollment":40},{"nctId":"NCT07490964","phase":"","title":"Polycystic Ovary Syndrome in Type 1 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal","startDate":"2026-04-01","conditions":"Type 1 Diabetes Mellitus, Polycystic Ovary Syndrome (PCOS)","enrollment":60},{"nctId":"NCT05123040","phase":"PHASE1, PHASE2","title":"Ruxolitinib, Human Chorionic Gonadotropin (uhCG/EGF), and Dose De-escalated Corticosteroids","status":"TERMINATED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2023-06-05","conditions":"Acute-graft-versus-host Disease","enrollment":10},{"nctId":"NCT00005927","phase":"","title":"Study of Adrenal Gland Tumors","status":"COMPLETED","sponsor":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","startDate":"2002-07-01","conditions":"Adrenal Gland Neoplasm","enrollment":690},{"nctId":"NCT07144163","phase":"PHASE3","title":"A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia","status":"RECRUITING","sponsor":"Crinetics Pharmaceuticals Inc.","startDate":"2025-12-11","conditions":"Congenital Adrenal Hyperplasia, Classic Congenital Adrenal Hyperplasia","enrollment":150},{"nctId":"NCT03867448","phase":"","title":"Study of Endocrine-Related Conditions and Physiology","status":"RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2019-03-27","conditions":"Endocrine Disease","enrollment":1000},{"nctId":"NCT00156767","phase":"","title":"Adrenal Function in Critical Illness","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2004-11-12","conditions":"Adrenal Insufficiency","enrollment":225},{"nctId":"NCT06780085","phase":"PHASE2","title":"A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-05-13","conditions":"Carcinoma, Non-Small-Cell Lung","enrollment":96},{"nctId":"NCT07480889","phase":"PHASE3","title":"Effect of Adding a Low-Dose Epinephrine Bolus Prior to Infusion on Maternal Hemodynamic Stability During Cesarean Section","status":"RECRUITING","sponsor":"Cairo University","startDate":"2026-03-18","conditions":"Hemodynamic (MAP) Stability","enrollment":100},{"nctId":"NCT03663335","phase":"PHASE2","title":"Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Kidney Transplant Recipients","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2018-11-28","conditions":"Kidney Transplantation","enrollment":418},{"nctId":"NCT06388564","phase":"PHASE2","title":"A Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease","status":"RECRUITING","sponsor":"Incyte Corporation","startDate":"2024-10-11","conditions":"Chronic Graft-versus-host-disease","enrollment":120},{"nctId":"NCT07187375","phase":"PHASE2","title":"Pharmacokinetics, Safety and Tolerability of Crinecerfont in Participants With Congenital Adrenal Hyperplasia Who Are Less Than 2 Years Old","status":"RECRUITING","sponsor":"Neurocrine Biosciences","startDate":"2025-09-30","conditions":"Congenital Adrenal Hyperplasia","enrollment":6},{"nctId":"NCT03221335","phase":"NA","title":"EUS-guided RFA for Solid Abdominal Neoplasms","status":"RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2016-05","conditions":"Digestive System Neoplasms","enrollment":30},{"nctId":"NCT06136624","phase":"PHASE3","title":"Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2023-12-31","conditions":"Prostate Cancer Metastatic","enrollment":1310},{"nctId":"NCT05967364","phase":"NA","title":"Career Enhancement Training Study Delivered Across Career Phases","status":"ENROLLING_BY_INVITATION","sponsor":"University of Rochester","startDate":"2025-01-27","conditions":"Suicide Prevention, Suicide","enrollment":2970},{"nctId":"NCT07169318","phase":"PHASE1","title":"First-in-Human Study of VNT-101: Safety, Tolerability, and Pharmacokinetics","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2025-09-16","conditions":"Influenza","enrollment":78},{"nctId":"NCT06131281","phase":"NA","title":"Comparing Reduction With ESD- Versus APC-TORe","status":"ACTIVE_NOT_RECRUITING","sponsor":"Stephen Firkins","startDate":"2023-10-02","conditions":"Obesity, Roux-en-y Anastomosis Site, Weight Gain","enrollment":70},{"nctId":"NCT05492578","phase":"PHASE2, PHASE3","title":"Long-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate to Severe Atopic Dermatitis Clinical Trials","status":"ENROLLING_BY_INVITATION","sponsor":"Sanofi","startDate":"2022-08-22","conditions":"Dermatitis Atopic","enrollment":1663},{"nctId":"NCT04924166","phase":"PHASE2","title":"PTSD Prevention Using Oral Hydrocortisone","status":"COMPLETED","sponsor":"Rachel Yehuda","startDate":"2022-01-12","conditions":"PTSD, Acute Stress Disorder, Trauma-related Stressor","enrollment":201},{"nctId":"NCT07012382","phase":"NA","title":"Single Gene Polymorphism and the Success Rate of Inferior Alveolar Nerve Block","status":"COMPLETED","sponsor":"Jamia Millia Islamia","startDate":"2025-05-10","conditions":"Pulpitis - Irreversible","enrollment":320},{"nctId":"NCT07159841","phase":"PHASE2, PHASE3","title":"A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)","status":"RECRUITING","sponsor":"Crinetics Pharmaceuticals Inc.","startDate":"2026-01-22","conditions":"Congenital Adrenal Hyperplasia, Classic Congenital Adrenal Hyperplasia","enrollment":153},{"nctId":"NCT06112548","phase":"NA","title":"The Efficiency of Periarticular Multimodal Drug Injection in Pain Management Following Primary Unilateral TKA","status":"COMPLETED","sponsor":"Damascus University","startDate":"2024-03-01","conditions":"Arthritis Knee, Pain, Arthroplasty Complications","enrollment":80},{"nctId":"NCT06136598","phase":"PHASE1","title":"A Study of Opevesostat (MK-5684) in China Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (MK-5684-001)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-01-30","conditions":"Prostatic Neoplasms, Metastatic Castration-Resistant Prostate Cancer","enrollment":14},{"nctId":"NCT07366788","phase":"NA","title":"Clinical Outcomes of Mandibular Primary Molar Extraction Using Physics Forceps in Children","status":"COMPLETED","sponsor":"Damascus University","startDate":"2025-05-21","conditions":"Dental Anxiety, Dental Pain, Dental Extraction","enrollment":80},{"nctId":"NCT06892197","phase":"PHASE4","title":"Comparing Hydrocortisone and Prednisolone for Community Acquired Pneumonia (CAP)","status":"RECRUITING","sponsor":"Copenhagen Respiratory Research","startDate":"2026-03-10","conditions":"Community Acquired Pneumonia (CAP)","enrollment":1600},{"nctId":"NCT06892210","phase":"PHASE4","title":"Comparing Hydrocortisone and Prednisolone for Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD)","status":"RECRUITING","sponsor":"Copenhagen Respiratory Research","startDate":"2026-03-10","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":2000},{"nctId":"NCT06550024","phase":"NA","title":"SakuraBead Used as Resorbable Embolic for Genicular Artery Embolization","status":"ACTIVE_NOT_RECRUITING","sponsor":"CrannMed","startDate":"2024-11-28","conditions":"Osteo Arthritis Knee, Joint Diseases, Musculoskeletal Diseases","enrollment":89},{"nctId":"NCT07190196","phase":"PHASE3","title":"A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease","status":"RECRUITING","sponsor":"Sanofi","startDate":"2025-09-26","conditions":"Immunoglobulin G4 Related Disease","enrollment":124},{"nctId":"NCT06618599","phase":"NA","title":"Mid-transverse Process Combined With Erector Spinae Block Versus Paravertebral Plane Block","status":"RECRUITING","sponsor":"Cairo University","startDate":"2024-10-01","conditions":"Lung Cancer","enrollment":60},{"nctId":"NCT07474714","phase":"PHASE3","title":"Hyaluronic Acid Injection in Idiopathic Carpal Tunnel Syndrome; is it Effective as Local Corticosteroids","status":"NOT_YET_RECRUITING","sponsor":"Minia University Hospital","startDate":"2026-02","conditions":"Carpal Tunnel Syndrome (CTS)","enrollment":60},{"nctId":"NCT07041736","phase":"NA","title":"Evaluating Postoperative Pain and Antibacterial Effect of Ultrasonic and 980 nm Diode Laser Combination","status":"RECRUITING","sponsor":"Al-Azhar University","startDate":"2025-08-03","conditions":"Post Operative Pain","enrollment":120},{"nctId":"NCT05435781","phase":"PHASE4","title":"Effect of Supplemental Hydrocortisone During Stress in Prednisolone-induced Adrenal Insufficiency","status":"RECRUITING","sponsor":"Marianne Christina Klose","startDate":"2022-06-07","conditions":"Adrenal Insufficiency, Polymyalgia Rheumatica, Giant Cell Arteritis","enrollment":250},{"nctId":"NCT07473804","phase":"","title":"Syndromes With Neonatal Salt Loss: Not Only Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency (21OH-ISC)","status":"RECRUITING","sponsor":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","startDate":"2025-04-14","conditions":"Neonatal Salt Loss, Congenital Adrenal Hyperplasia (CAH)","enrollment":25},{"nctId":"NCT05935761","phase":"PHASE2","title":"Investigating Novel Interventions for Low Back Pain in US Military Veterans: A Randomized Controlled Adaptive Phase II Trial","status":"NOT_YET_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2026-06-01","conditions":"Chronic Low Back Pain","enrollment":108},{"nctId":"NCT06585774","phase":"PHASE3","title":"A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease","status":"RECRUITING","sponsor":"Incyte Corporation","startDate":"2025-01-21","conditions":"Chronic Graft-versus-host-disease","enrollment":240},{"nctId":"NCT07264829","phase":"NA","title":"This Clinical Trial Aims to Compare the Effectiveness of Two Intra-pulpal Cryotherapy Techniques-Endo-ice and Ice Sticks-in Decreasing Intra-operative Pain and Enhancing the Success of Local Anesthesia During Pulpectomy of Mandibular Molars With Symptomatic Irreversible Pulpitis.","status":"NOT_YET_RECRUITING","sponsor":"Dow University of Health Sciences","startDate":"2026-04-15","conditions":"Root Canal Treatment, Intra-operative Pain, Symptomatic Irreversible Pulpitis","enrollment":90},{"nctId":"NCT00250159","phase":"","title":"Natural History Study of Patients With Excess Androgen","status":"RECRUITING","sponsor":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","startDate":"2006-01-02","conditions":"Congenital Adrenal Hyperplasia (CAH), Familial Male-Limited Precocious Puberty (FMPP)","enrollment":3000},{"nctId":"NCT07471555","phase":"NA","title":"Vascular Access and Intraosseus","status":"ENROLLING_BY_INVITATION","sponsor":"University of Valencia","startDate":"2026-04-02","conditions":"To Compare the Time Required to Administer 1 mg of Epinephrine, as Well as the Total Procedure","enrollment":52},{"nctId":"NCT04322357","phase":"PHASE2","title":"Twice Weekly Steroids and Exercise as Therapy for DMD","status":"COMPLETED","sponsor":"University of Florida","startDate":"2020-07-30","conditions":"Duchenne Muscular Dystrophy (DMD)","enrollment":21},{"nctId":"NCT06818175","phase":"NA","title":"Physical Exam, Static & Dynamic Ultrasound Assessment, & Treatment of Thoracolumbar Fascia (TLF) Mediated Low Back Pain","status":"RECRUITING","sponsor":"Edward Via Virginia College of Osteopathic Medicine","startDate":"2023-09-01","conditions":"Low Back Pain, Chronic Low-back Pain, Acute Low Back Pain","enrollment":200},{"nctId":"NCT05444439","phase":"NA","title":"Antibiotyping and Prevalence of Virulent Genotypes Among Helicobacter Pylori and Their Impact on Response to Therapy","status":"COMPLETED","sponsor":"Assiut University","startDate":"2024-01-20","conditions":"H Pylori Infection","enrollment":100},{"nctId":"NCT05379634","phase":"PHASE2","title":"A Study of Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2022-07-05","conditions":"Myositis","enrollment":36},{"nctId":"NCT06728748","phase":"","title":"Retrospective Multicentre Study on the Impact of Neonatal Screening for Congenital Adrenal Hyperplasia in Italy","status":"COMPLETED","sponsor":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","startDate":"2020-10-23","conditions":"Congenital Adrenal Hyperplasia","enrollment":29},{"nctId":"NCT07340463","phase":"PHASE2","title":"The Efficacy and Safety of Biologics (Belimumab/ Telitacicept) Induction Therapy in Proliferative Lupus Nephritis Patients for 6 Months Compared With Mycophenolate Mofetil Treatment","status":"RECRUITING","sponsor":"Nanjing University School of Medicine","startDate":"2025-12-08","conditions":"Systemic Lupus Erythematosus (SLE), Lupus Nephritis (LN)","enrollment":50},{"nctId":"NCT07468604","phase":"PHASE4","title":"Cervicothoracic Sympathetic Block Evaluation for Post COVID Condition","status":"NOT_YET_RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2026-04-01","conditions":"Autonomic Dysfunction","enrollment":78},{"nctId":"NCT06365437","phase":"PHASE2","title":"A Dose Escalation Study of TCD601 Compared to ATG in de Novo Renal Transplantation","status":"TERMINATED","sponsor":"ITB-Med LLC","startDate":"2021-06-06","conditions":"Kidney Transplantation","enrollment":33},{"nctId":"NCT06353529","phase":"PHASE4","title":"Postop Pain Management in Pituitary Tumour Patients","status":"RECRUITING","sponsor":"Hamilton Health Sciences Corporation","startDate":"2024-11-25","conditions":"Pituitary, Pain, Postoperative","enrollment":108},{"nctId":"NCT05292664","phase":"PHASE1","title":"Venetoclax Basket Trial for High Risk Hematologic Malignancies","status":"RECRUITING","sponsor":"Andrew E. Place, MD","startDate":"2023-03-29","conditions":"Myelodysplastic Syndromes, de Novo, Myelodysplastic Syndromes, Secondary, Myelodysplastic Syndromes, Previously Treated","enrollment":30},{"nctId":"NCT07463222","phase":"","title":"Neuroendocrine Response in Pediatric Febrile Seizures","status":"NOT_YET_RECRUITING","sponsor":"Aydin Adnan Menderes University","startDate":"2026-03","conditions":"Febrile Convulsion, Neuroendocrine Stress Response, Fever","enrollment":120},{"nctId":"NCT07464860","phase":"NA","title":"Feasibility of Breathwork Intervention With Older Adults After Knee Surgery","status":"NOT_YET_RECRUITING","sponsor":"University of Arizona","startDate":"2026-04-06","conditions":"Surgical Stress Response, Stress Physiological, Stress Physiology","enrollment":32},{"nctId":"NCT05784428","phase":"NA","title":"Single vs. Multiple Fraction Trial of Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastases/Progression","status":"RECRUITING","sponsor":"Robert Olson","startDate":"2025-04-16","conditions":"Oligometastatic Disease, Oligoprogression, Toxicity Due to Radiotherapy","enrollment":598},{"nctId":"NCT07100990","phase":"PHASE3","title":"Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX)","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-07-11","conditions":"Optic Neuritis, Myelitis, Myelitis, Transverse","enrollment":382},{"nctId":"NCT07461402","phase":"NA","title":"Plant Protein With Ashwagandha-Rhodiola for Sleep Quality","status":"COMPLETED","sponsor":"Universidad Pablo de Olavide","startDate":"2025-11-01","conditions":"Sleep Quality, Sleep Disorders, Insomnia","enrollment":100},{"nctId":"NCT06917937","phase":"NA","title":"The Additive Effect of Exercise in Addition to Corticosteroid Injection in Plantar Fasciitis","status":"COMPLETED","sponsor":"Kutahya Health Sciences University","startDate":"2018-09-16","conditions":"Plantar Fascitis","enrollment":40},{"nctId":"NCT05669950","phase":"PHASE1, PHASE2","title":"A Trial of Lu AG13909 in Participants With Congenital Adrenal Hyperplasia","status":"RECRUITING","sponsor":"H. Lundbeck A/S","startDate":"2022-12-19","conditions":"Congenital Adrenal Hyperplasia","enrollment":42},{"nctId":"NCT07206680","phase":"NA","title":"Effect of Extracorporeal Shockwave Therapy on Pruritus in Neurodermatitis Patients","status":"COMPLETED","sponsor":"Cairo University","startDate":"2024-12-15","conditions":"Neurodermatitis","enrollment":34},{"nctId":"NCT07457255","phase":"NA","title":"Late Endocrine and Metabolic Consequences After Childhood Brain Tumor Treatment","status":"COMPLETED","sponsor":"Institute of Oncology Ljubljana","startDate":"2023-01-01","conditions":"Childhood Brain Tumors, Endocrine Disorders","enrollment":12},{"nctId":"NCT05986318","phase":"PHASE2","title":"Reducing Respiratory Symptoms of Pulmonary Irradiation in Interstitial Lung Disease","status":"RECRUITING","sponsor":"David Palma","startDate":"2025-01-07","conditions":"Lung Cancer, Interstitial Lung Disease","enrollment":98},{"nctId":"NCT03297281","phase":"NA","title":"Stop or Ongoing Oral Anticoagulation in Patients Undergoing Pvp (SOAP)","status":"RECRUITING","sponsor":"Clinique Pasteur","startDate":"2017-10-30","conditions":"Benign Prostatic Hyperplasia, Anticoagulant Adverse Reaction","enrollment":389},{"nctId":"NCT04322435","phase":"NA","title":"Prevalence of Hypoglycaemia in Congenital Adrenal Insufficiency","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2020-07-15","conditions":"Adrenal Insufficiency, Congenital","enrollment":9},{"nctId":"NCT06979596","phase":"PHASE2","title":"A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-08-11","conditions":"Malignant Neoplasm","enrollment":250},{"nctId":"NCT06104449","phase":"PHASE1","title":"A Study of Opevesostat (MK-568)4 in Japanese Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-005)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2023-11-14","conditions":"Prostatic Neoplasms, Metastatic Castration-Resistant Prostate Cancer","enrollment":6},{"nctId":"NCT04206553","phase":"PHASE2, PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients With Bullous Pemphigoid","status":"COMPLETED","sponsor":"Regeneron Pharmaceuticals","startDate":"2020-10-28","conditions":"Bullous Pemphigoid","enrollment":106},{"nctId":"NCT05844930","phase":"PHASE4","title":"A Study to Determine the Safety and Effectiveness of a Connective Tissue Allograft (ActiveMatrix) Verses Standard of Care in Adhesive Capsulitis of the Shoulder","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2023-01-03","conditions":"Adhesive Capsulitis","enrollment":56},{"nctId":"NCT07245732","phase":"PHASE4","title":"Oral Versus Intramuscular Steroid Use to Control Rheumatoid Arthritis Flares","status":"NOT_YET_RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2026-04","conditions":"Rheumatoid Arthritis (RA)","enrollment":220},{"nctId":"NCT07247058","phase":"PHASE4","title":"Isturisa Treatment in Mild Autonomous Cortisol Secretion( MACS)","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2026-02-02","conditions":"Mild Autonomous Cortisol Secretion (MACS)","enrollment":10},{"nctId":"NCT05199584","phase":"PHASE2","title":"A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations","status":"COMPLETED","sponsor":"Endeavor Biomedicines, Inc.","startDate":"2022-05-24","conditions":"Solid Tumors With PTCH1 Loss-of-function Mutations","enrollment":20},{"nctId":"NCT05679401","phase":"PHASE3","title":"A Study With Imlifidase in Anti-GBM Disease","status":"TERMINATED","sponsor":"Hansa Biopharma AB","startDate":"2022-12-22","conditions":"Anti-Glomerular Basement Membrane Disease, Anti-Glomerular Basement Membrane Antibody Disease, Goodpasture Syndrome","enrollment":50},{"nctId":"NCT05789589","phase":"PHASE1, PHASE2","title":"Effect of Azeliragon Combined With Stereotactic Radiation Therapy in Patients With Brain Metastases","status":"RECRUITING","sponsor":"Baptist Health South Florida","startDate":"2023-11-17","conditions":"Cancer, Metastasis, Metastatic Cancer","enrollment":46},{"nctId":"NCT07383103","phase":"PHASE4","title":"Hydrocortisone and Fludrocortisone for the Treatment of Septic Shock","status":"RECRUITING","sponsor":"Northern Jiangsu People's Hospital","startDate":"2026-03-02","conditions":"Septic Shock","enrollment":336},{"nctId":"NCT06037811","phase":"PHASE2","title":"Early Adalimumab Induction for Immune Checkpoint Inhibitor Associated Inflammatory Arthritis","status":"RECRUITING","sponsor":"Tom Appleton","startDate":"2024-04-15","conditions":"Inflammatory Arthritis, Immune-related Adverse Event","enrollment":30},{"nctId":"NCT07221838","phase":"PHASE4","title":"A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With Ravulizumab","status":"NOT_YET_RECRUITING","sponsor":"Alexion Pharmaceuticals, Inc.","startDate":"2026-02-27","conditions":"Generalized Myasthenia Gravis, gMG","enrollment":75},{"nctId":"NCT06561269","phase":"NA","title":"Multifidus Plane Block Versus Caudal Block for Hypospadias","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2024-12-01","conditions":"Hypospadias, Caudal Block","enrollment":30},{"nctId":"NCT07442721","phase":"NA","title":"Sacral ESPB vs. PENG Block for Hip Hemiarthroplasty Analgesia","status":"RECRUITING","sponsor":"Fayoum University Hospital","startDate":"2026-02-01","conditions":"Hip Arthroplasty, Hip Fracture Surgeries, Femoral Neck Fractures","enrollment":80},{"nctId":"NCT06556277","phase":"NA","title":"Acute Consequences of Glucocorticoid Secretion in Overweight and Obese Individuals During Maximum Calorie Intake","status":"COMPLETED","sponsor":"Eleonora Seelig","startDate":"2024-09-01","conditions":"Glucocorticoids, Overweight and Obesity, Overeating","enrollment":23},{"nctId":"NCT06289673","phase":"PHASE4","title":"Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma","status":"RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2024-12-26","conditions":"Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Mixed Phenotype Acute Leukemia","enrollment":850},{"nctId":"NCT03237481","phase":"PHASE3","title":"Phase 3 Herniorrhaphy Study for Postoperative Analgesia (EPOCH 2)","status":"COMPLETED","sponsor":"Heron Therapeutics","startDate":"2017-07-31","conditions":"Postoperative Pain","enrollment":418},{"nctId":"NCT03015532","phase":"PHASE2","title":"Total Knee Arthroplasty Infiltration Study for Postoperative Analgesia","status":"COMPLETED","sponsor":"Heron Therapeutics","startDate":"2017-01-13","conditions":"Postoperative Pain","enrollment":285},{"nctId":"NCT06246513","phase":"PHASE3","title":"A Trial to Learn More About an Experimental Gene Therapy Called Bidridistrogene Xeboparvovec (SRP-9003) as a Possible Treatment for Limb Girdle Muscular Dystrophy 2E/R4","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sarepta Therapeutics, Inc.","startDate":"2024-01-15","conditions":"Limb-girdle Muscular Dystrophy","enrollment":17},{"nctId":"NCT03011333","phase":"PHASE2","title":"Phase 2B Upper Extremity Nerve Block Study","status":"COMPLETED","sponsor":"Heron Therapeutics","startDate":"2017-01-14","conditions":"Postoperative Pain","enrollment":243}],"_emaApprovals":[],"_faersSignals":[{"count":5,"reaction":"DEEP VEIN THROMBOSIS"},{"count":5,"reaction":"PULMONARY EMBOLISM"},{"count":3,"reaction":"DRUG HYPERSENSITIVITY"},{"count":3,"reaction":"DRUG INTERACTION"},{"count":3,"reaction":"MALAISE"},{"count":3,"reaction":"SYNCOPE"},{"count":2,"reaction":"AMNESIA"},{"count":2,"reaction":"ATRIOVENTRICULAR BLOCK SECOND DEGREE"},{"count":2,"reaction":"CARDIOGENIC SHOCK"},{"count":2,"reaction":"DELIRIUM"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":84,"therapeuticAreas":["Respiratory"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Epinephrin","genericName":"Epinephrin","companyName":"United States Naval Medical Center, San Diego","companyId":"united-states-naval-medical-center-san-diego","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":false,"indications":true,"safety":true,"trials":true,"score":3}}